[{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H2K1", "country": "Canada", "phone": "416 346 7764", "website": "https://www.psyencebiomed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 50, "title": "Co-Founder, Executive Chairman & CEO", "yearBorn": 1974, "fiscalYear": 2025, "totalPay": 216667, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warwick Ron Corden-Lloyd", "age": 44, "title": "CFO & Director", "yearBorn": 1980, "fiscalYear": 2025, "totalPay": 195000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "age": 60, "title": "Global Head of Clinical Development", "yearBorn": 1964, "fiscalYear": 2025, "totalPay": 390000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.81, "open": 1.81, "dayLow": 1.76, "dayHigh": 1.85, "regularMarketPreviousClose": 1.81, "regularMarketOpen": 1.81, "regularMarketDayLow": 1.76, "regularMarketDayHigh": 1.85, "payoutRatio": 0.0, "beta": 0.28, "volume": 60248, "regularMarketVolume": 60248, "averageVolume": 933631, "averageVolume10days": 286780, "averageDailyVolume10Day": 286780, "bid": 1.34, "ask": 2.18, "bidSize": 2, "askSize": 2, "marketCap": 3294809, "fiftyTwoWeekLow": 1.41, "fiftyTwoWeekHigh": 62.96, "allTimeHigh": 8730.0, "allTimeLow": 1.41, "fiftyDayAverage": 2.82146, "twoHundredDayAverage": 4.38497, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3855175, "profitMargins": 0.0, "floatShares": 1864376, "sharesOutstanding": 1872051, "sharesShort": 99249, "sharesShortPriorMonth": 130857, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.053000003, "heldPercentInsiders": 0.00184, "heldPercentInstitutions": 0.10065, "shortRatio": 0.79, "shortPercentOfFloat": 0.053000003, "impliedSharesOutstanding": 1872051, "bookValue": 6.339, "priceToBook": 0.2776463, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -3941597, "trailingEps": -62.4, "lastSplitFactor": "125:1000", "lastSplitDate": 1746403200, "enterpriseToEbitda": 0.93, "52WeekChange": -0.8937198, "SandP52WeekChange": 0.13506866, "quoteType": "EQUITY", "currentPrice": 1.76, "recommendationKey": "none", "totalCash": 7149985, "totalCashPerShare": 3.819, "ebitda": -4145455, "totalDebt": 0, "quickRatio": 7.766, "currentRatio": 8.09, "returnOnAssets": -0.34442002, "returnOnEquity": -0.74286, "freeCashflow": -4006023, "operatingCashflow": -4247508, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PBM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639146600000, "postMarketChangePercent": 0.5681813, "postMarketPrice": 1.77, "postMarketChange": 0.00999999, "regularMarketChange": -0.049999952, "regularMarketDayRange": "1.76 - 1.85", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 933631, "fiftyTwoWeekLowChange": 0.35000002, "fiftyTwoWeekLowChangePercent": 0.24822697, "fiftyTwoWeekRange": "1.41 - 62.96", "fiftyTwoWeekHighChange": -61.2, "fiftyTwoWeekHighChangePercent": -0.9720458, "fiftyTwoWeekChangePercent": -89.37198, "epsTrailingTwelveMonths": -62.4, "fiftyDayAverageChange": -1.06146, "fiftyDayAverageChangePercent": -0.3762095, "twoHundredDayAverageChange": -2.6249702, "twoHundredDayAverageChangePercent": -0.598629, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-01-26", "cryptoTradeable": false, "longName": "Psyence Biomedical Ltd.", "regularMarketChangePercent": -2.7624285, "regularMarketPrice": 1.76, "corporateActions": [], "postMarketTime": 1764981680, "regularMarketTime": 1764968400, "exchange": "NCM", "messageBoardId": "finmb_698500412", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Psyence Biomedical Ltd.", "displayName": "Psyence Biomedical", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]